Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
943,943
-
Shares change
-
+115,067
-
Total reported value, excl. options
-
$73,105,100
-
Value change
-
+$8,871,294
-
Number of buys
-
37
-
Number of sells
-
-26
-
Price
-
$77.37
Significant Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2021
99 filings reported holding PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS as of Q3 2021.
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 943,943 shares
.
Largest 10 shareholders include Peak Asset Management, LLC (120,882 shares), WELLINGTON MANAGEMENT GROUP LLP (95,748 shares), UBS Group AG (74,025 shares), LPL Financial LLC (59,245 shares), BANK OF AMERICA CORP /DE/ (57,124 shares), GOLDMAN SACHS GROUP INC (50,000 shares), MORGAN STANLEY (48,987 shares), Federation des caisses Desjardins du Quebec (42,305 shares), WELLS FARGO & COMPANY/MN (26,901 shares), and U.S. Capital Wealth Advisors, LLC (22,811 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.